Adaptive Biotechnologies (ADPT) Asset Utilization Ratio (2019 - 2026)

Adaptive Biotechnologies has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.54 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 31.91% year-over-year to 0.54; the TTM figure through Jun 2026 stood at 0.54 (up 31.91% YoY), while the FY2025 annual figure was 0.53, up 76.6% from the prior year.
• Asset Utilization Ratio came in at 0.54 for Q2 2026 at Adaptive Biotechnologies, down from 0.58 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.58 in Q1 2026 to a low of 0.17 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.33, with a median of 0.28 recorded in 2024.
• Year-over-year, Asset Utilization Ratio advanced 14.92% in 2024 and surged 69.36% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.21 in 2022, then rose by 16.01% to 0.25 in 2023, then jumped by 31.99% to 0.33 in 2024, then soared by 69.36% to 0.55 in 2025, then declined by 2.67% to 0.54 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.54 in Q2 2026, 0.58 in Q1 2026, and 0.55 in Q4 2025.